An extended follow-up study conducted at the University of Jyväskylä shows that low cardiorespiratory fitness in adolescence is associated with higher risk for cardiovascular and metabolic diseases in middle age.
Novo Nordisk to discontinue long-acting insulin Levemir next year amid incoming 65% price cut
Insulin powerhouse Novo Nordisk will discontinue its long-acting insulin Levemir in the US next year amid anticipated supply disruptions, a 65% price cut and as
November 9, 2023